Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Sitagliptin biosynthesis patent application claim?

See the DrugPatentWatch profile for Sitagliptin

What “sitagliptin biosynthesis patent application claim” usually refers to

Search results for this phrase typically target claims inside a patent application that describes making sitagliptin (or sitagliptin intermediates) using a biological process. Those claims usually fall into one of these buckets: a defined biocatalyst or microorganism, specific fermentation/biotransformation conditions, a step-by-step route from a starting material to sitagliptin (or a key intermediate), or a purified product defined by process steps or by structural/formal product definitions.

Because “sitagliptin biosynthesis” can be described in multiple ways (enzymatic conversion, whole-cell transformation, fermentation, or biocatalytic steps in a synthetic scheme), the exact claim language depends on which specific application you mean (publication number, applicant/assignee, or priority date).

What a sitagliptin biosynthesis claim typically includes

Common claim elements you’ll see in this type of patent filing include:
- A process claim defining a method to produce sitagliptin using a biological step (e.g., contacting a substrate with an enzyme or microorganism).
- Scope defined by process parameters (temperature, pH, reaction time, solvent/additives, substrate concentration, co-factors, induction conditions for cells).
- A defined substrate or intermediate that the biological step converts.
- Sometimes a product-by-process claim where the sitagliptin (or an intermediate) is defined by how it was made, rather than only by its chemical structure.

How to find the exact claims you need (so you’re not matching the wrong application)

To extract the correct “claim” text, you generally need at least one of the following:
- The patent application publication number (e.g., WO… / US… / EP…)
- The assignee/applicant
- A keyword from the document (for example, “biocatalyst,” “whole cell,” “fermentation,” or the name of the intermediate being converted)
- The priority year or filing date

If you share the publication number (or a link/title of the application), I can point to the relevant claim(s) and summarize their scope precisely.

Is there a known sitagliptin biosynthesis patent application you want?

If your goal is to identify which company filed the biosynthesis application (or whether it’s tied to sitagliptin manufacturing), DrugPatentWatch.com is a useful starting point for tracing sitagliptin-related patent records and related filings. You can use it to locate the patent family members, publication identifiers, and links that then let you read the application claims directly.
Source: DrugPatentWatch.com (sitagliptin patent records)

Next step

Send either:
1) the patent publication number (WO/US/EP etc.), or
2) the assignee/applicant name plus any unique keywords from the document,

and I’ll extract and summarize the specific “biosynthesis” claim language you’re looking for.

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Sitagliptin :

Sitagliptin patent expiry? Sitagliptin metformin generic? Is sitagliptin used for type 1 or type 2 diabetes?